Evidence map›Paper›PMID 36959733›Full record

ArticleCell transplantation

Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors:

Michiko Shigyo, Yoshiomi Kobayashi, Oleksandr Platoshyn, Silvia Marsala, Tomohisa Kato, Naoki Takamura, Kenji Yoshida, Akiyoshi Kishino, Mariana Bravo-Hernandez, Stefan Juhas and 5 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Unlocking the code for stroke treatment and care.Journal of central nervous system disease · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Michiko ShigyoDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Yoshiomi KobayashiDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Oleksandr PlatoshynDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Silvia MarsalaDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Tomohisa KatoRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan.
Naoki TakamuraRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan.
Kenji YoshidaRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan.
Akiyoshi KishinoRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan.
Mariana Bravo-HernandezDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Stefan JuhasInstitute of Animal Physiology and Genetics AS CR, v.v.i., Liběchov, Czech Republic.
Jana JuhasovaInstitute of Animal Physiology and Genetics AS CR, v.v.i., Liběchov, Czech Republic.
Hana StudenovskaDepartment of Biomaterials and Bioanalogous System, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic.
Vladimir ProksDepartment of Biomaterials and Bioanalogous System, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic.
Joseph D CiacciDepartment of Neurosurgery, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Martin MarsalaDepartment of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-5048-6422
University of California San Diego · USSumitomo Dainippon Pharma (Japan) · JPCzech Academy of Sciences, Institute of Animal Physiology and Genetics · CZCzech Academy of Sciences, Institute of Macromolecular Chemistry · CZKanazawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The critical requirements in developing clinical-grade human-induced pluripotent stem cells-derived neural precursors (hiPSCs-NPCs) are defined by expandability, genetic stability, predictable

Indexed as

Induced Pluripotent Stem CellsNeural Stem CellsAnimalsCell DifferentiationHumansLeukocytes, MononuclearNeuronsRatsSendai virusbrain graftinghuman-induced pluripotent stem cells (hiPSCs)immunodeficient ratmanual selectionneural precursor cells (NPCs)spinal cord grafting

Identifiers

PMID36959733
PMCPMC10041596
OpenAlexW4360803566

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read70
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.